DAVID MOON: Open Payments
NPI 1538469465 · HENRICO, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,484 in 122 payments from 20 companies in 2025. Trend: 2023 $2,498 · 2024 $2,996 · 2025 $2,484
Food & beverage: $2,389Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $509 |
| Regeneron Healthcare Solutions, Inc. | 14 | $334 |
| ARS Pharmaceuticals Operations, Inc. | 17 | $280 |
| GlaxoSmithKline, LLC. | 19 | $268 |
| Novartis Pharmaceuticals Corporation | 11 | $232 |
| Genentech USA, Inc. | 9 | $172 |
| CSL Behring | 6 | $115 |
| GENZYME CORPORATION | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Amgen Inc. | 4 | $64 |
Products named: DUPIXENT, NEFFY, NUCALA, XOLAIR, AIRSUPRA, TEZSPIRE, FASENRA, AYVAKIT.
Industry payments across VA — which companies pay providers there.
